The SLC19A1 gene helps move folate, a form of vitamin B9, into cells so they can make and repair DNA. This gene helps your body support normal cell growth and healthy blood cell production, and when it works poorly, some tissues may not get enough folate. Depending on the variant, this can influence blood counts, growth, and how the body handles methotrexate, a medicine used for cancer and some autoimmune conditions. SLC19A1 is mainly known in medical care and drug response testing rather than in popular culture.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or regulating activities in the body. Some genes hold the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a more detailed overview of this topic, you can visit the LearnHub.
Overview
SLC19A1Gene function
What if the gene works
The SLC19A1 gene helps move folate, a B vitamin, into cells. This supports DNA building, cell growth, and normal development.
Risk
What if the gene does not work
If SLC19A1 works less well, cells may take up less folate, a B vitamin needed to make and repair DNA. Milder variants may partly reduce transport, while more severe variants can cause a larger loss of folate movement into cells.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the SLC19A1 gene is currently established in clinical guidelines. The SLC19A1 gene is being studied as a biomarker for response and side effects with antifolate medicines such as methotrexate and pemetrexed, mainly in cancer and rheumatology care.
Gene function
What if the gene works
Many everyday cell tasks depend on a steady supply of folate, a form of vitamin B9. The SLC19A1 gene helps provide that supply by carrying folate into cells. This is a key part of how the SLC19A1 gene helps move folate into cells for everyday cell work.
Its protein sits in the cell membrane and carries folate, a form of vitamin B9, into many cells. This helps keep a usable folate supply available inside the cell.
Once folate is inside the cell, it helps make the building blocks of DNA. This supports accurate DNA copying as cells grow and divide.
A steady folate supply supports normal cell division and routine tissue renewal. This matters in everyday processes such as replacing blood cells and renewing the gut lining.
Folate also supports one-carbon metabolism (reactions that move tiny carbon pieces between molecules). These reactions help cells make DNA and carry out other routine jobs.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help explain normal differences among people, such as appearance, metabolism, or the way the body reacts to environmental influences. Many do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant changes how a gene works to a greater extent and may contribute to, or lead to, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC19A1 gene can change the shape, stability, or cell surface placement of its folate transporter, so less folate and some related drugs move into cells. This explains how variants affect the SLC19A1 gene at a molecular level: some missense variants may only partly reduce transport, while more disruptive variants can sharply lower or nearly stop uptake. In some cases, variants also weaken how well the transporter binds its cargo.
How variants are linked to conditions
Current evidence on how variants in the SLC19A1 gene are linked to conditions remains limited, and no specific health condition has a broadly confirmed connection at this time. Anyone with a confirmed diagnosis involving the SLC19A1 gene should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the SLC19A1 gene. Some changes in SLC19A1 have been studied alongside folate levels and certain medicines, but their effects can vary from person to person.
Inheritance of SLC19A1 variants
There is not yet a broadly confirmed, disease-specific inheritance pattern for the inheritance of SLC19A1 gene variants, and this picture may become clearer as research develops. The SLC19A1 gene is located on chromosome 21, which is an autosome rather than a sex chromosome. That means each person inherits one copy of the SLC19A1 gene from each parent.
What does my SLC19A1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the SLC19A1 gene, although this understanding can change as research develops. If you have a specific SLC19A1 result and want to know what it could mean for relatives, a doctor or genetic counselor can help put it in the right family context.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC19A1 gene, genetic testing looks at DNA from a blood sample, saliva, or a cheek swab. SLC19A1 genetic testing reads the gene's code and compares it with the usual sequence to identify variants. Results may show no variant, a benign variant, or one that helps explain a health finding.
When should I consider getting a genetic test?
There isn't yet a broadly established, SLC19A1-specific clinical reason for genetic testing in most people. Decisions about testing are usually based on your personal health history, family history, and the broader question your doctor or genetic counselor is trying to answer.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies by the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Small inherited differences can change how the body absorbs, moves, breaks down, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medicines. By studying links between genes and medications, it helps explain why the same treatment may work differently in different people. For many drugs, genes influence both how strongly the medicine works and how the body handles it. This information can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC19A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication decisions, so general questions about side effects, treatment changes, or medicine safety are best discussed with your doctor. SLC19A1 has been studied in how some people respond to methotrexate and other folate-related medicines, but this research is not yet used as standard guidance for routine care.
History
Research on the SLC19A1 gene grew out of decades of work on how cells take in folate, a vitamin needed for normal growth and blood cell production. Initially understood only through visible traits, later recognized as tied to a specific gene, this transport system became much clearer in the 1990s when researchers isolated and mapped the gene. That work helped connect earlier laboratory findings with inherited differences in folate handling and response to antifolate medicines such as methotrexate. From these first observations, research expanded steadily. Over time, studies of the SLC19A1 gene became part of broader efforts to understand nutrition, birth defect risk, and cancer treatment response. Its history is mainly scientific rather than public, but it has had a lasting place in folate and drug research.